Business Description
Adynxx Inc
NAICS : 325412
SIC : 2834
ISIN : US00784D1037
Description
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company developing therapeutics for pain and inflammation. The company focuses on transcription factor decoys, a class of drug candidates designed to modify disease processes rather than merely mask symptoms. Its lead pipeline candidate, brivoligide, was developed to address postoperative pain, while AYX2 was a preclinical candidate targeting chronic pain syndromes, including inflammatory and neuropathic pain. Adynxx's programs were aimed at reducing reliance on opioids and other conventional analgesics by intervening in the biological pathways that drive pain signaling. As a clinical-stage company, it did not market approved products and generated no product revenue, relying instead on equity financing, grants, and partnership arrangements to fund research and development. The company was based in the United States and conducted its development activities primarily in the U.S. market.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ADYX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adynxx Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.589 | ||
| EPS (TTM) ($) | -4.097 | ||
| Beta | 175.7414 | ||
| 3-Year Sharpe Ratio | -57.69 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.001583 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0401 | ||
| Shares Outstanding (Mil) | 5.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adynxx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adynxx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.166667:1 Stock Split | 2019-05-06 | 16.12 (+9.66%) | ||
| 0.1:1 Stock Split | 2017-10-06 | 20.11 (-3.12%) | ||
| 0.022857:1 Stock Split | 2013-11-19 | 207.38 (-11.04%) | ||
| 4:1 Stock Split | 2001-08-01 | 196.88 (+0.00%) |
Show
Entries
Adynxx Inc Frequently Asked Questions
What is Adynxx Inc(ADYX)'s stock price today?
The current price of ADYX is $0.00. The 52 week high of ADYX is $0.04 and 52 week low is $0.00.
When is next earnings date of Adynxx Inc(ADYX)?
The next earnings date of Adynxx Inc(ADYX) is .
Does Adynxx Inc(ADYX) pay dividends? If so, how much?
Adynxx Inc(ADYX) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers